Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CLEAN HARBORS INCCLH · Entity 3318 | Director | May 20, 2026 | May 22, 2026 |
| Celanese CorpCE · Entity 3922 | Director | August 10, 2026 | August 12, 2026 |
| LINDE PLCLIN · Entity 2835 | Director | March 08, 2023 | March 09, 2023 |
| Marathon Petroleum CorpMPC · Entity 2903 | Director | April 01, 2025 | April 03, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CLEAN HARBORS INC
Report date May 20, 2026 · Filed May 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 25,461 |
Reported balance
After 2026-05-20 transaction · row 1
1 source rowRow 1 · 2026-05-20 · Grant · Acquired 652 · Balance 25,461 F1: Award of restricted stock to non-employee director vesting 100% upon the date of the next annual meeting of shareholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Award of restricted stock to non-employee director vesting 100% upon the date of the next annual meeting of shareholders.
Celanese Corp
Report date August 10, 2026 · Filed August 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 27,983 |
Reported balance
After 2026-08-10 transaction · row 1
1 source rowRow 1 · 2026-08-10 · Grant · Acquired 1,930 · Balance 27,983 F1: Annual grant of fully vested restricted stock units pursuant to the Amended and Restated Company's 2018 Global Incentive Plan. The restricted stock units were granted to compensate the reporting person for his prior service as Chair of the Board. |
| Phantom StockSEC Table II · derivative / convertible security | Direct | 6,814.817 |
Reported balance
After 2026-08-10 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-08-10 · Grant · Acquired 4.595 · Balance 6,814.817 F2: Each share of phantom stock represents the right to receive one share of Common Stock. F3: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. |
Filing footnotes · ownership attribution and instrument terms
F1: Annual grant of fully vested restricted stock units pursuant to the Amended and Restated Company's 2018 Global Incentive Plan. The restricted stock units were granted to compensate the reporting person for his prior service as Chair of the Board.
F2: Each share of phantom stock represents the right to receive one share of Common Stock.
F3: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company.
LINDE PLC
Report date March 08, 2023 · Filed March 09, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 13,673.465 |
Reported balance
After 2023-03-08 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-03-08 · Exercise / conversion · Acquired 611.309 · Balance 13,673.465 F1: On March 1, 2023, Linde plc (formerly Rounderway plc), an Irish public limited company ("New Linde"), became the successor of Linde plc, an Irish public limited company ("Old Linde"), pursuant to a scheme of arrangement and merger under Irish law. Pursuant to the scheme of arrangement, all outstanding ordinary shares of Old Linde were exchanged, on a one-for-one basis, for ordinary shares of New Linde, and Old Linde subsequently merged into New Linde and ceased to exist. The transaction did not alter the relative interests of security holders. F2: Ordinary shares acquired pursuant to the payout of a restricted stock unit ("RSU") grant made on March 1, 2022. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2023-03-08 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-03-08 · Exercise / conversion · Disposed 611.309 · Balance 0 F1: On March 1, 2023, Linde plc (formerly Rounderway plc), an Irish public limited company ("New Linde"), became the successor of Linde plc, an Irish public limited company ("Old Linde"), pursuant to a scheme of arrangement and merger under Irish law. Pursuant to the scheme of arrangement, all outstanding ordinary shares of Old Linde were exchanged, on a one-for-one basis, for ordinary shares of New Linde, and Old Linde subsequently merged into New Linde and ceased to exist. The transaction did not alter the relative interests of security holders. F2: Ordinary shares acquired pursuant to the payout of a restricted stock unit ("RSU") grant made on March 1, 2022. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 8,919.563 |
Reported balance
Holding disclosure · report date 2023-03-08 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 8,919.563 F1: On March 1, 2023, Linde plc (formerly Rounderway plc), an Irish public limited company ("New Linde"), became the successor of Linde plc, an Irish public limited company ("Old Linde"), pursuant to a scheme of arrangement and merger under Irish law. Pursuant to the scheme of arrangement, all outstanding ordinary shares of Old Linde were exchanged, on a one-for-one basis, for ordinary shares of New Linde, and Old Linde subsequently merged into New Linde and ceased to exist. The transaction did not alter the relative interests of security holders. F3: RSUs that have fully vested but whose payout in Linde plc Ordinary Shares has been deferred by the reporting person until termination of service as a director or a specific future date. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 13,035.239 |
Reported balance
Holding disclosure · report date 2023-03-08 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 13,035.239 F1: On March 1, 2023, Linde plc (formerly Rounderway plc), an Irish public limited company ("New Linde"), became the successor of Linde plc, an Irish public limited company ("Old Linde"), pursuant to a scheme of arrangement and merger under Irish law. Pursuant to the scheme of arrangement, all outstanding ordinary shares of Old Linde were exchanged, on a one-for-one basis, for ordinary shares of New Linde, and Old Linde subsequently merged into New Linde and ceased to exist. The transaction did not alter the relative interests of security holders. F4: Conversion to Linde plc Ordinary Shares is on a one-for-one basis. F5: Deferred stock units acquired under the Linde Director's Fees Deferral Plan and are to be settled in Linde plc Ordinary Shares upon the reporting person's retirement or termination of service. |
Filing footnotes · ownership attribution and instrument terms
F1: On March 1, 2023, Linde plc (formerly Rounderway plc), an Irish public limited company ("New Linde"), became the successor of Linde plc, an Irish public limited company ("Old Linde"), pursuant to a scheme of arrangement and merger under Irish law. Pursuant to the scheme of arrangement, all outstanding ordinary shares of Old Linde were exchanged, on a one-for-one basis, for ordinary shares of New Linde, and Old Linde subsequently merged into New Linde and ceased to exist. The transaction did not alter the relative interests of security holders.
F2: Ordinary shares acquired pursuant to the payout of a restricted stock unit ("RSU") grant made on March 1, 2022.
F3: RSUs that have fully vested but whose payout in Linde plc Ordinary Shares has been deferred by the reporting person until termination of service as a director or a specific future date.
F4: Conversion to Linde plc Ordinary Shares is on a one-for-one basis.
F5: Deferred stock units acquired under the Linde Director's Fees Deferral Plan and are to be settled in Linde plc Ordinary Shares upon the reporting person's retirement or termination of service.
Marathon Petroleum Corp
Report date April 01, 2025 · Filed April 03, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 23,975.907 |
Reported balance
After 2025-04-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-04-01 · Grant · Acquired 93.586 · Balance 23,975.907 F1: Represents the reporting person's second quarter 2025 equity retainer award prorated for the period beginning April 1, 2025 and ending April 30, 2025. F2: Includes 115.894 shares acquired pursuant to dividend reinvestment and not previously reported pursuant to Rule 16a-11. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the reporting person's second quarter 2025 equity retainer award prorated for the period beginning April 1, 2025 and ending April 30, 2025.
F2: Includes 115.894 shares acquired pursuant to dividend reinvestment and not previously reported pursuant to Rule 16a-11.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ANDEAVOR LLC
Report date October 01, 2018 · Filed October 02, 2018
Section 16 reporting ended · disclosed 2018-10-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-10-01 transaction · row 1
1 source rowRow 1 · 2018-10-01 · Disposition to issuer · Disposed 5,017 · Balance 0 F1: Includes 1,145 restricted stock units. F2: Pursuant to the Agreement and Plan of Merger, dated as of April 29, 2018, by and among the Issuer, Marathon Petroleum Corporation ("MPC"), Mahi Inc. and Mahi LLC (as amended, the "Merger Agreement"), at the effective time, each outstanding share of the Issuer's common stock was cancelled and became exchangeable for, at the holder's election, either $152.27 in cash or 1.87 shares of MPC common stock, subject to an allocation and proration whereby the outstanding shares of Issuer's common stock would be exchanged for approximately $3.5 billion in cash with the balance of shares exchanged for MPC shares, and each restricted stock unit was accelerated and cancelled in exchange for $152.27 in cash. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2018-10-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-10-01 · Disposition to issuer · Disposed 2,035 · Balance 0 F3: Pursuant to the Merger Agreement, at the effective time, each restricted stock unit for which the reporting person had previously elected to defer distribution was accelerated and cancelled in exchange for $152.27 in cash. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 1,145 restricted stock units.
F2: Pursuant to the Agreement and Plan of Merger, dated as of April 29, 2018, by and among the Issuer, Marathon Petroleum Corporation ("MPC"), Mahi Inc. and Mahi LLC (as amended, the "Merger Agreement"), at the effective time, each outstanding share of the Issuer's common stock was cancelled and became exchangeable for, at the holder's election, either $152.27 in cash or 1.87 shares of MPC common stock, subject to an allocation and proration whereby the outstanding shares of Issuer's common stock would be exchanged for approximately $3.5 billion in cash with the balance of shares exchanged for MPC shares, and each restricted stock unit was accelerated and cancelled in exchange for $152.27 in cash.
F3: Pursuant to the Merger Agreement, at the effective time, each restricted stock unit for which the reporting person had previously elected to defer distribution was accelerated and cancelled in exchange for $152.27 in cash.
PRAXAIR INC
Report date October 31, 2018 · Filed November 01, 2018
Section 16 reporting ended · disclosed 2018-11-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 1
1 source rowRow 1 · 2018-10-31 · Disposition to issuer · Disposed 13,229 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-10-31 · Disposition to issuer · Disposed 7,734.173 · Balance 0 F2: Restricted Stock Units ("RSUs") that have vested in full but whose payout was deferred. In connection with the BCA, the RSUs have been converted into RSUs of Linde plc Ordinary Shares on a one-for-one basis. F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-10-31 · Disposition to issuer · Disposed 12,134.526 · Balance 0 F3: Conversion to Praxair Common Stock is on a 1-for-1 basis. F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F4: Deferred stock units ("DSUs") acquired by reporting person under the Praxair, Inc. Director's Fees Deferral Plan. In connection with the BCA, the DSUs have been conveerted into DSUs of Linde plc Ordinary Shares on a one-for-one basis. F5: This total includes shares previously acquired through automatic dividend reinvestment under the Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.
F2: Restricted Stock Units ("RSUs") that have vested in full but whose payout was deferred. In connection with the BCA, the RSUs have been converted into RSUs of Linde plc Ordinary Shares on a one-for-one basis.
F3: Conversion to Praxair Common Stock is on a 1-for-1 basis.
F4: Deferred stock units ("DSUs") acquired by reporting person under the Praxair, Inc. Director's Fees Deferral Plan. In connection with the BCA, the DSUs have been conveerted into DSUs of Linde plc Ordinary Shares on a one-for-one basis.
F5: This total includes shares previously acquired through automatic dividend reinvestment under the Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2018 Filed Oct 2, 2018 21:34 UTC | ANDEAVOR LLC ANDV · Entity 143162 | Disposition to issuerCommon Stock | 5,017 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-18-025934 · doc4.xml · nonDerivative · entry 1 GALANTE EDWARD G · CIK 0001199009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Includes 1,145 restricted stock units. F2 · price: Pursuant to the Agreement and Plan of Merger, dated as of April 29, 2018, by and among the Issuer, Marathon Petroleum Corporation ("MPC"), Mahi Inc. and Mahi LLC (as amended, the "Merger Agreement"), at the effective time, each outstanding share of the Issuer's common stock was cancelled and became exchangeable for, at the holder's election, either $152.27 in cash or 1.87 shares of MPC common stock, subject to an allocation and proration whereby the outstanding shares of Issuer's common stock would be exchanged for approximately $3.5 billion in cash with the balance of shares exchanged for MPC shares, and each restricted stock unit was accelerated and cancelled in exchange for $152.27 in cash. Read SEC document |
| October 01, 2018 Filed Oct 2, 2018 18:16 UTC | PRAXAIR INC PX · Entity 162268 | GrantDeferred Stock Units · Derivative | 170.249 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000884905-18-000065 · edgar.xml · derivative · entry 1 GALANTE EDWARD G · CIK 0001199009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,134.526 Underlying: Common Stock · 170.249 shares Expires not disclosed F1 · derivative.exercise_price: Conversion to Praxair Common Stock is on a 1-for-1 basis. F2 · derivative.exercise_date: Deferred stock units acquired by reporting person under the Praxair, Inc. Director's Fees Deferral Plan and are to be settled in Praxair Common Stock upon the reporting person's retirement or termination of service. F2 · derivative.expiration_date: Deferred stock units acquired by reporting person under the Praxair, Inc. Director's Fees Deferral Plan and are to be settled in Praxair Common Stock upon the reporting person's retirement or termination of service. F3 · balance_after: This total includes shares previously acquired through automatic dividend reinvestment under the Plan. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 23:38 UTC | Marathon Petroleum Corp MPC · Entity 2903 | GrantCommon Stock | 409.438 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-054148 · doc4.xml · nonDerivative · entry 2 GALANTE EDWARD G · CIK 0001199009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,823.438 Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 23:38 UTC | Marathon Petroleum Corp MPC · Entity 2903 | GrantCommon Stock | 6,299 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-054148 · doc4.xml · nonDerivative · entry 1 GALANTE EDWARD G · CIK 0001199009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,414 F1 · price: Received in exchange for 3,872 shares of Andeavor common stock in connection with the merger of Mahi Inc., a wholly owned subsidiary of the Issuer, with and into Andeavor on October 1, 2018, with Andeavor as the surviving entity (the "Merger"). F2 · price: In connection with the Merger, holders of Andeavor common stock elected to receive, per share of Andeavor common stock, 1.87 shares of Issuer common stock or $152.27 in cash, subject to allocation and proration provisions set forth in the merger agreement, with cash paid in lieu of fractional shares. On the effective date of the Merger, the closing price of Issuer common stock was $82.43 per share. F3 · price: All reported amounts are estimated as of October 3, 2018 based on preliminary information with respect to the Merger and such cash/stock elections. Final amounts will be reported in a subsequent filing. Read SEC document |
| August 06, 2018 Filed Aug 7, 2018 20:29 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 27.174 | $116.60 | $3,168.49 |
DisclosureSEC source: 0001306830-18-000184 · wf-form4_153367374128557.xml · derivative · entry 1 GALANTE EDWARD G · CIK 0001199009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,894.778 Underlying: Series A Common Stock · 27.174 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Series A Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| July 02, 2018 Filed Jul 3, 2018 18:40 UTC | PRAXAIR INC PX · Entity 162268 | GrantDeferred Stock Units · Derivative | 181.64 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000884905-18-000054 · edgar.xml · derivative · entry 1 GALANTE EDWARD G · CIK 0001199009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,900.783 Underlying: Common Stock · 181.64 shares Expires not disclosed F1 · derivative.exercise_price: Conversion to Praxair Common Stock is on a 1-for-1 basis. F2 · derivative.exercise_date: Deferred stock units acquired by reporting person under the Praxair, Inc. Director's Fees Deferral Plan and are to be settled in Praxair Common Stock upon the reporting person's retirement or termination of service. F2 · derivative.expiration_date: Deferred stock units acquired by reporting person under the Praxair, Inc. Director's Fees Deferral Plan and are to be settled in Praxair Common Stock upon the reporting person's retirement or termination of service. F3 · balance_after: This total includes shares previously acquired through automatic dividend reinvestment under the Plan. Read SEC document |
| June 06, 2018 Filed Jun 7, 2018 19:59 UTC | CLEAN HARBORS INC CLH · Entity 3318 | GrantCommon Stock | 2,236 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-008202 · edgar.xml · nonDerivative · entry 1 GALANTE EDWARD G · CIK 0001199009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,864 F1 · security: Award of restricted stock to non-employee director vesting 100% on June 6, 2019. Read SEC document |
| May 10, 2018 Filed May 14, 2018 21:07 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 28.768 | $109.60 | $3,152.97 |
DisclosureSEC source: 0001306830-18-000140 · wf-form4_152633198222494.xml · derivative · entry 1 GALANTE EDWARD G · CIK 0001199009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,867.604 Underlying: Series A Common Stock · 28.768 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Series A Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| May 04, 2018 Filed May 8, 2018 21:39 UTC | ANDEAVOR LLC ANDV · Entity 143162 | GrantCommon Stock | 1,145 | $0.00 | $0.00 |
DisclosureSEC source: 0000050104-18-000106 · wf-form4_152582992000315.xml · nonDerivative · entry 1 GALANTE EDWARD G · CIK 0001199009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,017 F1 · security: Annual non-employee director restricted stock unit award granted under the Issuer's 2018 Long-Term Incentive Plan. The restricted stock units are scheduled to vest on the first anniversary of the grant date. Read SEC document |
| April 24, 2018 Filed Apr 26, 2018 18:16 UTC | PRAXAIR INC PX · Entity 162268 | GrantCommon Stock | 1,105 | $0.00 | $0.00 |
DisclosureSEC source: 0000884905-18-000036 · edgar.xml · nonDerivative · entry 1 GALANTE EDWARD G · CIK 0001199009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,175.521 F1 · shares: Restricted stock unit award, vesting 100% and payable in shares of Praxair Common Stock one year after April 24, 2018 if the awardee is serving on the Praxair, Inc. Board of Directors on that vesting date, unless termination of service occurs in connection with certain events, in which case the grant will vest in full. Read SEC document |
| April 20, 2018 Filed Apr 24, 2018 20:38 UTC | Celanese Corp CE · Entity 3922 | GrantSeries A Common Stock | 1,372 | $0.00 | $0.00 |
DisclosureSEC source: 0001306830-18-000119 · wf-form4_152460226764178.xml · nonDerivative · entry 1 GALANTE EDWARD G · CIK 0001199009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,670 F1 · shares: Annual grant of restricted stock units pursuant to the Company's 2009 Global Incentive Plan, as amended and restated. The restricted stock units vest in full on the one-year anniversary of the date of grant. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 18:23 UTC | PRAXAIR INC PX · Entity 162268 | GrantDeferred Stock Units · Derivative | 202.322 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000884905-18-000024 · edgar.xml · derivative · entry 1 GALANTE EDWARD G · CIK 0001199009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,659.124 Underlying: Common Stock · 202.322 shares Expires not disclosed F1 · derivative.exercise_price: Conversion to Praxair Common Stock is on a 1-for-1 basis. F2 · derivative.exercise_date: Deferred stock units acquired by reporting person under the Praxair, Inc. Director's Fees Deferral Plan and are to be settled in Praxair Common Stock upon the reporting person's retirement or termination of service. F2 · derivative.expiration_date: Deferred stock units acquired by reporting person under the Praxair, Inc. Director's Fees Deferral Plan and are to be settled in Praxair Common Stock upon the reporting person's retirement or termination of service. F3 · balance_after: This total includes shares previously acquired through automatic dividend reinvestment under the Plan. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:35 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 25.558 | $104.63 | $2,674.13 |
DisclosureSEC source: 0001306830-18-000059 · wf-form4_152037209526117.xml · derivative · entry 1 GALANTE EDWARD G · CIK 0001199009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,838.836 Underlying: Series A Common Stock · 25.558 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Series A Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| January 02, 2018 Filed Jan 3, 2018 21:39 UTC | PRAXAIR INC PX · Entity 162268 | GrantDeferred Stock Units · Derivative | 184.07 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000884905-18-000003 · edgar.xml · derivative · entry 1 GALANTE EDWARD G · CIK 0001199009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,396.405 Underlying: Common Stock · 184.07 shares Expires not disclosed F1 · derivative.exercise_price: Conversion to Praxair Common Stock is on a 1-for-1 basis. F2 · derivative.exercise_date: Deferred stock units acquired by reporting person under the Praxair, Inc. Director's Fees Deferral Plan and are to be settled in Praxair Common Stock upon the reporting person's retirement or termination of service. F2 · derivative.expiration_date: Deferred stock units acquired by reporting person under the Praxair, Inc. Director's Fees Deferral Plan and are to be settled in Praxair Common Stock upon the reporting person's retirement or termination of service. F3 · balance_after: This total includes shares previously acquired through automatic dividend reinvestment under the Plan. Read SEC document |
| November 09, 2017 Filed Nov 13, 2017 21:56 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 25.373 | $104.93 | $2,662.39 |
DisclosureSEC source: 0001306830-17-000249 · wf-form4_151061017844362.xml · derivative · entry 1 GALANTE EDWARD G · CIK 0001199009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,813.278 Underlying: Series A Common Stock · 25.373 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Series A Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| October 31, 2017 Filed Nov 2, 2017 19:35 UTC | PRAXAIR INC PX · Entity 162268 | Exercise / conversionStock Option (right to buy) · Derivative | 3,885 | $0.00 Strike: $83.89 | $0.00 |
DisclosureSEC source: 0000884905-17-000075 · edgar.xml · derivative · entry 3 GALANTE EDWARD G · CIK 0001199009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,885 shares Expires 2018-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. Read SEC document |
| October 31, 2017 Filed Nov 2, 2017 19:35 UTC | PRAXAIR INC PX · Entity 162268 | Tax withholdingCommon Stock | 2,217 | $147.02 | $325,943.34 |
DisclosureSEC source: 0000884905-17-000075 · edgar.xml · nonDerivative · entry 2 GALANTE EDWARD G · CIK 0001199009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,366.334 F1 · shares: Shares of common stock withheld to pay the option exercise price and taxes. No market sale of shares occurred. The reporting person acquired and held 1,668 shares net of the shares withheld. Read SEC document |
| October 31, 2017 Filed Nov 2, 2017 19:35 UTC | PRAXAIR INC PX · Entity 162268 | Exercise / conversionCommon Stock | 3,885 | $83.89 | $325,912.65 |
DisclosureSEC source: 0000884905-17-000075 · edgar.xml · nonDerivative · entry 1 GALANTE EDWARD G · CIK 0001199009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,583.334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 02, 2017 Filed Oct 3, 2017 21:30 UTC | PRAXAIR INC PX · Entity 162268 | GrantDeferred Stock Units · Derivative | 203.626 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000884905-17-000069 · edgar.xml · derivative · entry 1 GALANTE EDWARD G · CIK 0001199009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,153.622 Underlying: Common Stock · 203.626 shares Expires not disclosed F1 · derivative.exercise_price: Conversion to Praxair Common Stock is on a 1-for-1 basis. F2 · derivative.exercise_date: Deferred stock units acquired by reporting person under the Praxair, Inc. Director's Fees Deferral Plan and are to be settled in Praxair Common Stock upon the reporting person's retirement or termination of service. F2 · derivative.expiration_date: Deferred stock units acquired by reporting person under the Praxair, Inc. Director's Fees Deferral Plan and are to be settled in Praxair Common Stock upon the reporting person's retirement or termination of service. F3 · balance_after: This total includes shares previously acquired through automatic dividend reinvestment under the Plan. Read SEC document |
| August 07, 2017 Filed Aug 8, 2017 20:37 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 26.828 | $98.78 | $2,650.07 |
DisclosureSEC source: 0001306830-17-000199 · wf-form4_150222463277291.xml · derivative · entry 1 GALANTE EDWARD G · CIK 0001199009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,787.905 Underlying: Series A Common Stock · 26.828 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Series A Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| July 03, 2017 Filed Jul 5, 2017 20:23 UTC | PRAXAIR INC PX · Entity 162268 | GrantDeferred Stock Units · Derivative | 214.264 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000884905-17-000061 · edgar.xml · derivative · entry 1 GALANTE EDWARD G · CIK 0001199009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,886.125 Underlying: Common Stock · 214.264 shares Expires not disclosed F1 · derivative.exercise_price: Conversion to Praxair Common Stock is on a 1-for-1 basis. F2 · derivative.exercise_date: Deferred stock units acquired by reporting person under the Praxair, Inc. Director's Fees Deferral Plan and are to be settled in Praxair Common Stock upon the reporting person's retirement or termination of service. F2 · derivative.expiration_date: Deferred stock units acquired by reporting person under the Praxair, Inc. Director's Fees Deferral Plan and are to be settled in Praxair Common Stock upon the reporting person's retirement or termination of service. F3 · balance_after: This total includes shares previously acquired through automatic dividend reinvestment under the Plan. Read SEC document |
| June 07, 2017 Filed Jun 9, 2017 12:49 UTC | CLEAN HARBORS INC CLH · Entity 3318 | GrantCommon Stock | 2,057 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-008790 · edgar.xml · nonDerivative · entry 1 GALANTE EDWARD G · CIK 0001199009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,628 F1 · security: Award of restricted stock to non-employee director vesting 100% on June 7, 2018 Read SEC document |
| May 11, 2017 Filed May 12, 2017 20:08 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 30.651 | $86.00 | $2,635.99 |
DisclosureSEC source: 0001306830-17-000155 · wf-form4_149461970227718.xml · derivative · entry 1 GALANTE EDWARD G · CIK 0001199009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,761.077 Underlying: Series A Common Stock · 30.651 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Series A Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| May 04, 2017 Filed May 8, 2017 19:18 UTC | ANDEAVOR LLC TSO · Entity 143162 | GrantCommon Stock | 2,028 | $0.00 | $0.00 |
DisclosureSEC source: 0000050104-17-000121 · wf-form4_149428548788456.xml · nonDerivative · entry 1 GALANTE EDWARD G · CIK 0001199009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,872 F1 · security: Annual non-employee director restricted stock unit award granted under the Amended and Restated Tesoro Corporation 2011 Long-Term Incentive Plan. The restricted stock units, along with their accrued dividend equivalent rights, will vest on the first anniversary of the grant date. Read SEC document |
| April 25, 2017 Filed Apr 27, 2017 20:44 UTC | PRAXAIR INC PX · Entity 162268 | GrantCommon Stock | 1,357 | $0.00 | $0.00 |
DisclosureSEC source: 0000884905-17-000034 · edgar.xml · nonDerivative · entry 1 GALANTE EDWARD G · CIK 0001199009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,617.052 F1 · shares: Restricted stock unit award, vesting 100% and payable in shares of Praxair Common Stock one year after April 25, 2017 if the awardee is serving on the Praxair, Inc. Board of Directors on that vesting date, unless termination of service occurs in connection with certain events, in which case the grant will vest in full. Read SEC document |
| April 21, 2017 Filed Apr 24, 2017 20:31 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 1,717 | $0.00 | $0.00 |
DisclosureSEC source: 0001306830-17-000136 · wf-form4_149306589319681.xml · derivative · entry 3 GALANTE EDWARD G · CIK 0001199009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,730.426 Underlying: Series A Common Stock · 1,717 shares Expires not disclosed F3 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Series A Common Stock. F4 · derivative.exercise_date: As provided in the 2008 Deferred Compensation Plan, on the earlier date previously elected by the reporting person to receive payment or the termination of the reporting person's service as a director of the Company, the reported phantom stock becomes payable in shares of Series A Common Stock subject to certain limitations. F4 · derivative.expiration_date: As provided in the 2008 Deferred Compensation Plan, on the earlier date previously elected by the reporting person to receive payment or the termination of the reporting person's service as a director of the Company, the reported phantom stock becomes payable in shares of Series A Common Stock subject to certain limitations. Read SEC document |
| April 21, 2017 Filed Apr 24, 2017 20:31 UTC | Celanese Corp CE · Entity 3922 | Disposition to issuerSeries A Common Stock | 1,717 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001306830-17-000136 · wf-form4_149306589319681.xml · nonDerivative · entry 2 GALANTE EDWARD G · CIK 0001199009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,298 F2 · price: Upon vesting of 1,717 Restricted Stock Units granted to the reporting person on April 21, 2016, the reporting person deferred the receipt of 1,717 shares of Series A Common Stock and received instead 1,717 shares of phantom stock pursuant to the Company's 2008 Deferred Compensation Plan. As a result, the reporting person is reporting the disposition of 1,717 shares of Series A Common Stock in exchange for an equal number of shares of phantom stock. Read SEC document |
| April 20, 2017 Filed Apr 24, 2017 20:31 UTC | Celanese Corp CE · Entity 3922 | GrantSeries A Common Stock | 1,601 | $0.00 | $0.00 |
DisclosureSEC source: 0001306830-17-000136 · wf-form4_149306589319681.xml · nonDerivative · entry 1 GALANTE EDWARD G · CIK 0001199009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,015 F1 · shares: Annual grant of restricted stock units pursuant to the Company's 2009 Global Incentive Plan, as Amended and Restated February 9, 2017. The restricted stock units vest in full on the one-year anniversary of the date of grant. Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 19:14 UTC | PRAXAIR INC PX · Entity 162268 | GrantDeferred Stock Units · Derivative | 243.644 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000884905-17-000023 · edgar.xml · derivative · entry 1 GALANTE EDWARD G · CIK 0001199009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,610.054 Underlying: Common Stock · 243.644 shares Expires not disclosed F1 · derivative.exercise_price: Conversion to Praxair Common Stock is on a 1-for-1 basis. F2 · derivative.exercise_date: Deferred stock units acquired by reporting person under the Praxair, Inc. Director's Fees Deferral Plan and are to be settled in Praxair Common Stock upon the reporting person's retirement or termination of service. F2 · derivative.expiration_date: Deferred stock units acquired by reporting person under the Praxair, Inc. Director's Fees Deferral Plan and are to be settled in Praxair Common Stock upon the reporting person's retirement or termination of service. F3 · balance_after: This total includes shares previously acquired through automatic dividend reinvestment under the Plan. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 21:53 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 15.992 | $89.99 | $1,439.12 |
DisclosureSEC source: 0001306830-17-000082 · wf-form4_148892357909601.xml · derivative · entry 1 GALANTE EDWARD G · CIK 0001199009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,013.426 Underlying: Series A Common Stock · 15.992 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Series A Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 20:24 UTC | PRAXAIR INC PX · Entity 162268 | Exercise / conversionStock Option (right to buy) · Derivative | 540 | $0.00 Strike: $85.79 | $0.00 |
DisclosureSEC source: 0000884905-17-000015 · edgar.xml · derivative · entry 3 GALANTE EDWARD G · CIK 0001199009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 540 shares Expires 2017-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 20:24 UTC | PRAXAIR INC PX · Entity 162268 | Tax withholdingCommon Stock | 385 | $120.57 | $46,417.53 |
DisclosureSEC source: 0000884905-17-000015 · edgar.xml · nonDerivative · entry 2 GALANTE EDWARD G · CIK 0001199009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,223.3431 F1 · shares: Shares of common stock withheld to pay the exercise price of the stock option. There was no market sale of any shares. The 540 shares acquired upon the option exercise, net of 385 shares used to pay the exercise price, resulted in 155 shares that were acquired and held. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 20:24 UTC | PRAXAIR INC PX · Entity 162268 | Exercise / conversionCommon Stock | 540 | $85.79 | $46,326.60 |
DisclosureSEC source: 0000884905-17-000015 · edgar.xml · nonDerivative · entry 1 GALANTE EDWARD G · CIK 0001199009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,608.343 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 15:24 UTC | ANDEAVOR LLC TSO · Entity 143162 | Exercise / conversionRestricted Stock Units · Derivative | 334 | $0.00 | $0.00 |
DisclosureSEC source: 0001507615-17-000038 · wf-form4_148857267052596.xml · derivative · entry 2 GALANTE EDWARD G · CIK 0001199009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,035 Underlying: Common Stock · 334 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Vesting and settlement of restricted stock units previously granted under the Amended and Restated Tesoro Corporation 2011 Long-Term Incentive Plan. F1 · derivative.exercise_price: Vesting and settlement of restricted stock units previously granted under the Amended and Restated Tesoro Corporation 2011 Long-Term Incentive Plan. F2 · derivative.exercise_date: The restricted stock units were granted on March 1, 2016 and vested on the first anniversary of the grant date. F2 · derivative.expiration_date: The restricted stock units were granted on March 1, 2016 and vested on the first anniversary of the grant date. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 15:24 UTC | ANDEAVOR LLC TSO · Entity 143162 | Exercise / conversionCommon Stock | 334 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001507615-17-000038 · wf-form4_148857267052596.xml · nonDerivative · entry 1 GALANTE EDWARD G · CIK 0001199009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,844 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Vesting and settlement of restricted stock units previously granted under the Amended and Restated Tesoro Corporation 2011 Long-Term Incentive Plan. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 22:19 UTC | PRAXAIR INC PX · Entity 162268 | GrantDeferred Stock Units · Derivative | 245.936 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000884905-17-000002 · edgar.xml · derivative · entry 1 GALANTE EDWARD G · CIK 0001199009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,298.043 Underlying: Common Stock · 245.936 shares Expires not disclosed F1 · derivative.exercise_price: Conversion to Praxair Common Stock is on a 1-for-1 basis. F2 · derivative.exercise_date: Deferred stock units acquired by reporting person under the Praxair, Inc. Director's Fees Deferral Plan and are to be settled in Praxair Common Stock upon the reporting person's retirement or termination of service. F2 · derivative.expiration_date: Deferred stock units acquired by reporting person under the Praxair, Inc. Director's Fees Deferral Plan and are to be settled in Praxair Common Stock upon the reporting person's retirement or termination of service. F3 · balance_after: This total includes shares previously acquired through automatic dividend reinvestment under the Plan. Read SEC document |
| November 10, 2016 Filed Nov 14, 2016 22:51 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 18.775 | $76.29 | $1,432.34 |
DisclosureSEC source: 0001306830-16-000436 · wf-form4_147916386363902.xml · derivative · entry 1 GALANTE EDWARD G · CIK 0001199009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,997.434 Underlying: Series A Common Stock · 18.775 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Series A Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| October 03, 2016 Filed Oct 4, 2016 21:11 UTC | PRAXAIR INC PX · Entity 162268 | GrantDeferred Stock Units · Derivative | 237.132 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000884905-16-000175 · edgar.xml · derivative · entry 1 GALANTE EDWARD G · CIK 0001199009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,991.397 Underlying: Common Stock · 237.132 shares Expires not disclosed F1 · derivative.exercise_price: Conversion to Praxair Common Stock is on a 1-for-1 basis. F2 · derivative.exercise_date: Deferred stock units acquired by reporting person under the Praxair, Inc. Director's Fees Deferral Plan and are to be settled in Praxair Common Stock upon the reporting person's retirement or termination of service. F2 · derivative.expiration_date: Deferred stock units acquired by reporting person under the Praxair, Inc. Director's Fees Deferral Plan and are to be settled in Praxair Common Stock upon the reporting person's retirement or termination of service. F3 · balance_after: This total includes shares previously acquired through automatic dividend reinvestment under the Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.